Povidone Iodine vaginal cleansing trial

Preoperative versus Postoperative Vaginal Cleansing with Povidone-Iodine and Postoperative Infectious Morbidity: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202112553386036

Enrollment

480

Registered

2021-12-01

Start date

2019-09-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Postoperative infectious morbidity

Interventions

Postoperative vaginal cleansing group

Preoperative vaginal cleansing

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All consented parturient Undergoing elective or emergency caesarean section After the age of fetal viability (= 28weeks gestational age).

Exclusion criteria

Exclusion criteria: Refusal of consent. Women with known allergy to topical Povidone-iodine or on treatment with iodine or radiotherapy Placenta praevia. Cord prolapse Face presentation with ruptured membranes to avoid contact of fetal face with iodine. Ruptured uterus Thyroid disorders

Design outcomes

Primary

Measure	Time frame
The primary outcome measure was post caesarean endometritis	—

Secondary

Measure	Time frame
Post-caesarean wound infection Postoperative fever Duration of hospitalisation due to infectious morbidity. Adverse reaction to povidone iodine	—

Countries

Nigeria

Contacts

Public ContactIkechukwu O. Ugadu

Consultant AEFUTHA

ugaduike@gmail.com+2347032339988

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026